凝血因子VIII调节了·维勒布兰德因子在体内的恒温
Wenjing Cao1, Aria R Trask2, Antonia I Bignotti2
1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA; Institute of Reproductive Medicine and Developmental Sciences, The University of Kansas Medical Center, Kansas City, Kansas, USA.
Journal of thrombosis and haemostasis : JTH
|September 19, 2023
概括
凝血因子VIII (FVIII) 调节了·维勒布兰德因子 (VWF) 的分解和血液中的水平. 这项研究表明,FVIII对VWF大小和数量产生影响,这对于血友病A治疗和了解VWF恒温至关重要.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 凝血因子VIII (FVIII) 和·维勒布兰德因子 (VWF) 构成一个复合体,对血友病治疗有影响.
- 对于FVIII在调节VWF稳态中的确切作用,人们对其理解尚不完全.
研究的目的:
- 调查FVIII对·维勒布兰德因子 (VWF) 蛋白质分解和整体平衡的体内影响.
- 在各种生理和病理条件下阐明FVIII和VWF之间的功能关系.
主要方法:
- 使用了小鼠模型,包括缺少Adamts13的小鼠,并给出了被删除FVIII (BDD-FVIII) 的复合B域.
- 采用腺相关病毒血清型8 (AAV8) 载体用于血友病A小鼠的持续FVIII表达.
- 在接受治疗的小鼠和接受免疫耐受性诱导治疗的血友病A患者中分析了血VWF多元大小和抗原水平.
主要成果:
- 重组FVIII输液显著降低了野生型和血友病A型小鼠的血VWF多重体大小和抗原水平.
- 由FVIII诱导的VWF降解显示部分依赖ADAMTS-13活动.
- 在A型血友病患者中观察到减少的VWF多重体大小,这些患者接受了FVIII治疗以诱导免疫耐受性.
结论:
- 凝血因子VIII (FVIII) 作为蛋白质分解和·维勒布兰德因子 (VWF) 恒温的关键辅因子.
- 这些发现强调了FVIII在各种 (病理) 生理状态的VWF处理中的重要作用.
- 了解这种FVIII-VWF相互作用对于优化血友病A治疗和管理出血障碍至关重要.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
8.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.2K
Clot Retraction and Fibrinolysis
6.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
747
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
747
Formation of the Platelet Plug
6.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.6K
Coagulation
7.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.0K
Disorders of Hemostasis
987
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
987


